Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

ANG Lifesciences India Ltd - 540694 - Outcome Of Board Meeting And Disclosure Of Event Or Information Under Regulation 30 Of The SEBI (LODR) Regulations, 2015

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that the Board of Directors of the Company in its meeting held on today, 05th April, 2023 at its registered office at SCO 113, Darbara Complex, First Floor, District Shopping Centre B Block, Ranjit Avenue, Amritsar, Punjab, 143001, have inter-alia discussed and considered the matters as per document enclosed.
05-04-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Closure of Trading Window

 We wish to inform you that in pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015 as amended from time to time read with the Company's code of conduct to regulate, monitor and report the trading of equity shares, the Trading window for dealing in Equity shares of the Company for all Designated Persons covered under Company's Code of Conduct for prevention of Insider Trading in securities will be closed till the 48 hours after the declaration of Audited Financial Result of the Company for the Quarter and Financial year ended on 31st March, 2023. Further as per our earlier letter no. ANG/22-23/BSE-110 dated 28.03.2023, the trading window has been already closed. The date of Board meeting for consideration of the said financial results would be intimated to the Stock Exchange in due course of time.
31-03-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Meeting Updates

 Pursuant to the applicable provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), we are informing the agendas mentioned herewith disclosure.
28-03-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 & 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of Newspaper Advertisement published on 13tt-March, 2023, one in the English Newspaper having nationwide circulation- Business Standard and one in Vernacular Newspaper - Desh Sewak intimating the shareholders about Extra Ordinary General Meeting of our company to be heid on O1* April, 2023 at 12:00 P.M through Video Conferencing/other Audio-Visual Means (OAVM).
15-03-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Notice Of Extra Ordinary General Meeting Of The Company.

 Due to some inadvertent error we submitted the incorrect file of Notice of EGM. Therefore we hereby submitted the final copy of notice of EGM. The EGM will be held on Saturday, 01st April, 2023 at 12:00 p.m. (IST) through Video Conferencing ("VC")/Other Audio-Visual Means ("OAVM").
10-03-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Notice Of Extra Ordinary General Meeting Of The Company.

 Pursuant to Regulation 30 read with Part A of Schedule III, we are enclosing herewith a copy of notice of the Extra Ordinary General Meeting (EGM) of ANG Lifesciences India Ltd ("the Company'') to be held on Saturday, 01st April, 2023 at 12:00 p.m. (IST) through Video Conferencing ("VC")/Other Audio-Visual Means ("OAVM"). The said Notice is being sent only through e-mails to the shareholders of the Company at their registered e-mail addresses and the same has also been uploaded on the website of the Company at www.anglifesciences.com The Company has fixed Saturday, 25th March, 2023 as the "Cut-off-Date" for the purpose of determining the eligibility of the members entitled to vote by remote e-voting. Those shareholders holding shares either in dematerialized form or in physical form, as on the close of business hours on Saturday, 25th March, 2023 will be entitled to avail the facility of remote e-voting as well as voting at the EGM.
10-03-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Outcome Of Board Meeting And Disclosure Of Event Or Information Under Regulation 30 Of The SEBI (LODR) Regulations, 2015

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, We hereby inform you that the Board of Directors of the Company have , considered and approved the following: 1. Increase in Authorised Share Capital of the Company 2. Issue, offer and allot upto 22,00,000 warrants convertible into 22,00,000 Equity Shares of Rs. 10 each on preferential basis to the ANG Capital Investments Private Limited. (Issue price of the Convertible warrants is Rs. 110.00 each. ) 3.Calling an Extra Ordinary General Meeting (EGM) and approved the Notice of Extra Ordinary General Meeting (EGM) of the Members of the Company for EGM to be held on Saturday, 1st April, 2023 at 12:00 P.M. through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM') Means 4. Appointment of M/s. Anjum Goyal & Associates, Practicing Company Secretary as Scrutinizer
06-03-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting.

 ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/03/2023 ,inter alia, to consider and approve This is to inform you that, pursuant to the Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors is scheduled to be held on Monday, 06th March, 2023 inter-alia, to transact the business as per copy enclosed
27-02-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 & 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of Newspaper Advertisement of the Unaudited Financial Results (Standalone & Consolidated) for the Quarter & Nine months ended on 31-Dec-2022, published in the English Newspaper having nationwide circulation -Business Standard and one in Vernacular Newspaper - Desh Sewak on Wednesday, 16-Feb-2023.
17-02-2023
Bigul

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 & 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of Newspaper Advertisement of the Unaudited Financial Results (Standalone & Consolidated) for the Quarter & Nine months ended on 31-Dec-2022, published in the English Newspaper having nationwide circulation -Business Standard and one in Vernacular Newspaper - Desh Sewak on Wednesday, 16-Feb-2023.
17-02-2023
Next Page
Close

Let's Open Free Demat Account